Tapewire

Nasdaq · USD

TMDX

TransMedics Group, Inc.

Export transactions ↓
Tapewire entity
4261
SEC CIK
0001756262
Parsed reports
356

Last 12 months

Inside the activity.

2 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202511
Dec 202502
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 13, 2023 Filed Jan 17, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 5,900 $60.20 $355,180.00
Disclosure

SEC source: 0000899243-23-001859 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 13, 2023 Filed Jan 17, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 5,900 $16.00 $94,400.00
Disclosure

SEC source: 0000899243-23-001859 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,100 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000899243-23-001013 · doc4.xml · derivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,185

Underlying: Common Stock · 4,100 shares

Expires 2029-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 500 $62.79 $31,395.00
Disclosure

SEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.52 to $62.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 2,700 $61.99 $167,373.00
Disclosure

SEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,800

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.45 to $62.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
SaleCommon Stock 900 $60.93 $54,837.00
Disclosure

SEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.42 to $61.37, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 17:00 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 4,100 $16.00 $65,600.00
Disclosure

SEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 4,740 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 9

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,063

Underlying: Common Stock · 4,740 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 250 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 8

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,803

Underlying: Common Stock · 250 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
SaleCommon Stock 4,740 $58.96 $279,470.40
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 6

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.92 to $59.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
Exercise / conversionCommon Stock 4,740 $38.46 $182,300.40
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 5

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
SaleCommon Stock 250 $60.02 $15,005.00
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 4

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
Exercise / conversionCommon Stock 250 $38.46 $9,615.00
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 3

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 5,947 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 7

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,053

Underlying: Common Stock · 5,947 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
SaleCommon Stock 5,947 $62.43 $371,271.21
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 2

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.00 to $62.91, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:30 UTC
DAMME LAURAVP, Clinical Affairs
Exercise / conversionCommon Stock 5,947 $38.46 $228,721.62
Disclosure

SEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 1

DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,947

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 5,918 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-22-038601 · doc4.xml · derivative · entry 4

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,105

Underlying: Common Stock · 5,918 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
SaleCommon Stock 1,620 $63.00 $102,060.00
Disclosure

SEC source: 0000899243-22-038601 · doc4.xml · nonDerivative · entry 3

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,154

F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.72 to $63.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
SaleCommon Stock 2,695 $62.24 $167,736.80
Disclosure

SEC source: 0000899243-22-038601 · doc4.xml · nonDerivative · entry 2

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,774

F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.70 to $62.69, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
Exercise / conversionCommon Stock 5,918 $38.46 $227,606.28
Disclosure

SEC source: 0000899243-22-038601 · doc4.xml · nonDerivative · entry 1

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 1,149 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-22-038318 · doc4.xml · derivative · entry 8

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,226

Underlying: Common Stock · 1,149 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 3,977 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-22-038318 · doc4.xml · derivative · entry 7

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,023

Underlying: Common Stock · 3,977 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
SaleCommon Stock 567 $59.00 $33,453.00
Disclosure

SEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 5

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,551

F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
Exercise / conversionCommon Stock 1,149 $16.14 $18,544.86
Disclosure

SEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 4

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
SaleCommon Stock 3,046 $59.00 $179,714.00
Disclosure

SEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 3

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,969

F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:30 UTC
Provost MiriamVP, Global Regulatory Affairs
Exercise / conversionCommon Stock 3,977 $38.46 $152,955.42
Disclosure

SEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 2

Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 36 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 14

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36 shares

Expires 2023-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 05, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 36 $0.28 $10.08
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 9

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 13

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 10,000 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 6,800 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 12

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,800 shares

Expires 2023-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 6,237 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 11

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36

Underlying: Common Stock · 6,237 shares

Expires 2023-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
SaleCommon Stock 10,000 $63.50 $635,000.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 8

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,808

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.50 to $63.55, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 10,000 $38.46 $384,600.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 7

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 6,800 $0.28 $1,904.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 6

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 6,237 $0.28 $1,746.36
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 5

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 17:29 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 11,051 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0000899243-22-037661 · doc4.xml · derivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,051 shares

Expires 2027-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 17:29 UTC
Khayal Tamer IChief Commercial Officer
Exercise / conversionCommon Stock 11,051 $2.21 $24,422.71
Disclosure

SEC source: 0000899243-22-037661 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Tamer Ibrahim Ahmed Khayal Trust

Disclosed balance after: 11,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 10

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,273

Underlying: Common Stock · 3,000 shares

Expires 2023-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The option is fully vested.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
SaleCommon Stock 100 $62.45 $6,245.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 4

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 771

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
SaleCommon Stock 1,403 $61.70 $86,565.10
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 3

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 871

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.29 to $61.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
SaleCommon Stock 1,497 $60.83 $91,062.51
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 2

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,274

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.23 to $61.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Carey John FVP of Operations
Exercise / conversionCommon Stock 3,000 $0.28 $840.00
Disclosure

SEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 1

Carey John F · CIK 0001774272 · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:30 UTC
Gordon StephenChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-22-037662 · doc4.xml · derivative · entry 4

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,728

Underlying: Common Stock · 10,000 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:30 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 31 $62.15 $1,926.65
Disclosure

SEC source: 0000899243-22-037662 · doc4.xml · nonDerivative · entry 3

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,714

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.10 to $62.15, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:30 UTC
Gordon StephenChief Financial Officer
SaleCommon Stock 9,969 $61.30 $611,099.70
Disclosure

SEC source: 0000899243-22-037662 · doc4.xml · nonDerivative · entry 2

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,745

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.05 to $62.04, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:30 UTC
Gordon StephenChief Financial Officer
Exercise / conversionCommon Stock 10,000 $16.14 $161,400.00
Disclosure

SEC source: 0000899243-22-037662 · doc4.xml · nonDerivative · entry 1

Gordon Stephen · CIK 0001774274 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
November 23, 2022 Filed Nov 23, 2022 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,657 $0.00 Strike: $47.82 $0.00
Disclosure

SEC source: 0000899243-22-036935 · doc4.xml · derivative · entry 9

Lovell Stephanie · CIK 0001772054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,543

Underlying: Common Stock · 5,657 shares

Expires 2031-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.

Read SEC document
November 23, 2022 Filed Nov 23, 2022 21:30 UTC SaleCommon Stock 5,657 $59.50 $336,591.50
Disclosure

SEC source: 0000899243-22-036935 · doc4.xml · nonDerivative · entry 6

Lovell Stephanie · CIK 0001772054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 23, 2022 Filed Nov 23, 2022 21:30 UTC Exercise / conversionCommon Stock 5,657 $47.82 $270,517.74
Disclosure

SEC source: 0000899243-22-036935 · doc4.xml · nonDerivative · entry 5

Lovell Stephanie · CIK 0001772054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 22, 2022 Filed Nov 23, 2022 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,100 $0.00 Strike: $26.26 $0.00
Disclosure

SEC source: 0000899243-22-036935 · doc4.xml · derivative · entry 8

Lovell Stephanie · CIK 0001772054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,150

Underlying: Common Stock · 1,100 shares

Expires 2031-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.